Indianapolis, IN, United States of America

Upinder Singh

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Upinder Singh. Retrieved from https://idiyas.com/inventor/upinder-singh-vt20ciib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Upinder Singh: Innovator in Migraine Treatment

Introduction

Upinder Singh is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of medicine, particularly in the treatment of migraines. Her innovative work has led to the development of novel compounds that can potentially improve the quality of life for many individuals suffering from this debilitating condition.

Latest Patents

Upinder Singh holds a patent for "Serotonin 5-HT.sub.1F agonists." This invention provides novel 5-HT.sub.1F agonists of a specific formula, which are useful for the prevention and treatment of migraine and associated disorders. The patent highlights her commitment to advancing medical science and finding effective solutions for migraine sufferers.

Career Highlights

Upinder Singh is currently employed at Eli Lilly and Company, a leading pharmaceutical company known for its innovative research and development in healthcare. Her role at Eli Lilly allows her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Upinder has worked alongside talented colleagues, including Stephen W. Kaldor and Sidney Xi Liang. These collaborations have fostered an environment of innovation and creativity, leading to advancements in the treatment of migraines.

Conclusion

Upinder Singh's contributions to the field of medicine, particularly through her patent on serotonin agonists, demonstrate her dedication to improving patient care. Her work at Eli Lilly and her collaborations with esteemed colleagues further highlight her impact in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…